Non-aspirin NSAIDs use is associated with lowering of liver fibrosis scores in patients with fatty liver disease
Crossref DOI link: https://doi.org/10.30574/wjarr.2021.10.1.0165
Published Online: 2021-04-30
Update policy: https://doi.org/10.30574/wjarr.ourcrossmarkpolicy
Ikechukwu Ronald Ogbu,
Hossein Akhondi asl,
Napatkamon Ayutyanont,
Andre Manov,
Vignan Manne,
